Makes implantable lenses for eye surgery to correct myopia and hyperopia.
Jul 2026Revenue $340M/yrExpenses $326M/yr
No trend
Figures by year
Is Staar Surgical profitable?
Yes. In the 12 months to Jul 2026, revenue was $340M and expenses $326M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jan 2026 | $239M | $331M | −$91.7M |
| Dec 2024 | $314M | $327M | −$12.6M |
| Dec 2023 | $322M | $294M | $28.1M |
| Dec 2022 | $239M | $196M | $43.8M |
| Dec 2021 | $230M | $197M | $33.3M |
| Jan 2021 | $163M | $157M | $6.77M |
| Jan 2020 | $150M | $138M | $11.9M |
| Dec 2018 | $124M | $117M | $6.59M |
| Dec 2017 | $90.6M | $94.2M | −$3.63M |
| Dec 2016 | $82.4M | $95.1M | −$12.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.